Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Clin Cancer Res. 2009 Nov 17;15(23):7375–7380. doi: 10.1158/1078-0432.CCR-09-1910

Table 6.

Summary of survival times compared to expected.*

Dose Vehicle Number with Longer Survival Percent with Longer Survival
106 Aqueous 1/3 33
106 Matrix 2/3 67
107 Aqueous 3/3 100
107 Matrix 1/3 33
108 Aqueous 5/9 56
108 Matrix 5/10 50
Aqueous – all doses 9/15 60
Matrix – all doses 8/16 50
All patients 17/31 55
*

Expected survival times calculated using Halabi nomogram (6)